The 5 most recent market catalysts affecting $BCSF, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 17, 2026
Corporate Catalyst
Bearish
Impact 55
Kaskela Law Firm Announces Investigation of Bain Capital Specialty Finance, Inc.
Kaskela Law Firm announced an investigation into Bain Capital Specialty Finance, Inc. (BCSF) on behalf of its shareholders. The firm is looking into whether BCSF's officers and dir…
Nov 10, 2026
Corporate Catalyst
Neutral
Impact 75
Bain Capital Specialty Finance Reports Third Quarter 2026 Financial Results
Bain Capital Specialty Finance (BCSF) announced its third-quarter 2026 financial results, revealing a decrease in both total investment income and net investment income. This is a …
Sep 18, 2026
Corporate Catalyst
Neutral
Impact 55
LUCID CAPITAL MARKETS Initiates Coverage On Bain Capital Specialty with Neutral Rating, Announces Price Target of $12.5
LUCID CAPITAL MARKETS analyst Ethan Kaye has initiated coverage on Bain Capital Specialty (BCSF), assigning a 'Neutral' rating and a price target of $12.5. This event is significan…
Aug 17, 2026
Corporate Catalyst
Bearish
Impact 65
Keefe, Bruyette & Woods Downgrades Bain Capital Specialty to Market Perform, Lowers Price Target to $13
Keefe, Bruyette & Woods (KBW) analyst Paul Johnson downgraded Bain Capital Specialty (BCSF) from 'Outperform' to 'Market Perform' and lowered the price target from $15 to $13. This…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 75
Bain Capital Specialty Q2 EPS $0.44 Beats $0.42 Estimate, Sales $62.348M Miss $64.439M Estimate
Bain Capital Specialty (BCSF) announced Q2 earnings where EPS of $0.44 surpassed the $0.42 estimate, which is a positive signal for profitability. However, sales of $62.348 million…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.